Journal of Oncology Research

ISSN (Print):
ISSN (Online): 2630-5267
APC: ¥: 2200 CNY
Databases: ✥CNKI,
Publishing Time: Acceptance 5-6 Months

Journal of Oncology Research is a specialized English journal on oncology published and distributed by Synergy Publishing Pte. Ltd., issued semi-annually. Focusing on cutting-edge research in the field of oncology, the journal mainly publishes original research papers, review articles and case studies covering cancer chemotherapy, cancer prevention, viral oncology, carcinogenic mechanisms, angiogenesis, tumor biomarkers, radiotherapy and biotherapy, oncology clinical trials, cancer nanotechnology and other relevant research directions. Committed to building an academic exchange platform for oncology researchers and clinicians worldwide, it promotes the innovative development of basic oncology research and clinical diagnosis and treatment.


Aims & Scope

Journal of Oncology Research is a specialized English journal on oncology published and distributed by Synergy Publishing Pte. Ltd., issued semi-annually. Focusing on cutting-edge research in the field of oncology, the journal mainly publishes original research papers, review articles and case studies covering cancer chemotherapy, cancer prevention, viral oncology, carcinogenic mechanisms, angiogenesis, tumor biomarkers, radiotherapy and biotherapy, oncology clinical trials, cancer nanotechnology and other relevant research directions. Committed to building an academic exchange platform for oncology researchers and clinicians worldwide, it promotes the innovative development of basic oncology research and clinical diagnosis and treatment.

Aims

  • To provide a global academic and clinical professional platform for oncology basic researchers, clinical oncologists, pharmaceutical R&D specialists, radiotherapists, laboratory technicians, oncology educators, and cancer health policymakers to share, promote, and discuss innovative original studies, clinical trial discoveries, and frontier breakthroughs across all branches of oncology and interdisciplinary tumor research fields.
  • To facilitate the rapid dissemination of comprehensive, evidence-based research information on cutting-edge advances in cancer prevention, tumor molecular mechanism research, multimodal tumor therapy and cancer nanomedicine, and foster cross-disciplinary collaboration among global tumor scientists, frontline clinical physicians and biomedical engineering practitioners.
  • To bridge the gap between fundamental oncology theoretical research and real-world clinical tumor diagnosis, individualized chemotherapy administration and translational clinical trial implementation, promoting the translation of research findings into standardized tumor prevention regimens, novel targeted therapeutic innovations, and evidence-based clinical treatment best practices for global cancer care systems.
  • To encourage in-depth multi-dimensional exploration and innovative translational research on emerging oncology research trends, hot malignant tumor prevention and control issues, and practical clinical challenges in drug biomarker detection, anti-tumor angiogenesis therapy and nanoscale cancer treatment, supporting sustained theoretical progress and standardized clinical professional development of global oncology researchers and practitioners.

Scope

Journal of Oncology Research covers a wide range of topics related to cutting-edge oncology research, tumor clinical diagnosis and treatment, translational cancer medicine and interdisciplinary biomedical oncology subjects, including but not limited to:

Oncology Research & Fundamental Theory

  • Original empirical and theoretical research on foundational oncology, tumor cell biology and core molecular oncology disciplines
  • Cutting-edge theoretical explorations of carcinogenic molecular mechanisms, viral oncogenesis pathways and tumor angiogenesis regulatory logic
  • Fundamental theoretical research on tumor biomarker screening mechanisms, cancer nanomaterial delivery systems and cancer epidemiological prevention frameworks
  • Basic theoretical analysis of tumor immune response, radiotherapy biological effects, clinical trial design principles and cross-cancer comparative pathogenesis research

Oncology Review & Clinical Practical Application

  • Critical systematic reviews of oncology basic research progress, global academic frontier trends and international cancer clinical treatment system development
  • Evaluation of tumor prevention intervention projects, multimodal chemotherapy & biotherapy schemes and real-world clinical trial operation practices
  • Application of novel tumor detection technologies, molecular biomarker analysis platforms and nanomedicine treatment systems in clinical diagnosis and academic laboratory research
  • Case studies, short communications, and practical clinical diagnosis insights for oncologists, tumor pathologists and cancer translational research specialists
  • Comparative cross-regional cancer epidemiological research, global tumor medical resource layout planning, and international interdisciplinary oncology academic exchange activities


Journal of Oncology Research welcomes high-quality original research papers, comprehensive systematic review articles, clinical case studies, short communications, and other peer-reviewed scholarly contributions that advance fundamental theoretical research and clinical diagnosis & treatment practice of cancer chemotherapy, cancer prevention, viral oncology, carcinogenic mechanisms, angiogenesis, tumor biomarkers, radiotherapy and biotherapy, oncology clinical trials, cancer nanotechnology and all other interdisciplinary oncology fields. All submitted manuscripts undergo rigorous international peer review to guarantee academic rigor, clinical translational practicability, research originality and multi-modal tumor treatment relevance, with the goal of building a high-profile, forward-looking global academic community dedicated to promoting worldwide oncology theoretical innovation and standardized high-quality development of global cancer prevention and clinical care through rigorous translational tumor research and cross-disciplinary clinical academic exchange.